Evaluation of primary prevention ICD efficacy in late elderly heart failure patients: a multicenter study
The benefit of primary prevention implantable cardioverter defibrillator (ICD) in heart failure (HF) patients aged ≥75 years, particularly those with significant non-cardiac comorbidities, is questionable. We aimed to evaluate the clinical yield of primary prevention ICD in late-elderly HF patients. A mult...